Related Experiment Videos
Islet Cell Replacement and Regeneration for Type 1 Diabetes: Current Developments and Future Prospects
Arthur Rech Tondin1,2, Giacomo Lanzoni3,4
1Diabetes Research Institute, University of Miami Miller School of Medicine, Miami, FL, USA.
Summary
Type 1 diabetes (T1D) treatments are improving with islet cell transplantation and stem cell therapies. These advanced strategies aim to restore natural insulin production and enhance glycemic control for better patient outcomes.
Area of Science:
- Endocrinology and Immunology
- Regenerative Medicine
Background:
- Type 1 diabetes (T1D) involves autoimmune destruction of pancreatic beta cells, causing insulin deficiency and hyperglycemia.
- Current therapies like insulin injections offer suboptimal glycemic control, highlighting the need for advanced treatments.
Purpose of the Study:
- To review current and emerging islet replacement strategies for Type 1 diabetes.
- To discuss advancements in transplantation, immunoengineering, and regenerative approaches for T1D management.
Main Methods:
- Overview of islet transplantation and stem cell-derived islet cell transplantation.
- Examination of immunoengineering, encapsulation, and immunomodulation techniques.
- Discussion of gene editing and islet regeneration strategies.
Main Results:
- Islet cell transplantation offers functional replacement of insulin production for glycemic stability.
- Advancements in immunosuppression and protective techniques are improving graft survival.
- Emerging strategies show potential for durable islet integration and regeneration.
Conclusions:
- Islet replacement therapies, including stem cell-derived and engineered approaches, hold significant promise for transforming T1D management.
- Continued research in graft survival, immune protection, and regeneration is crucial for long-term success.
- These innovations aim to significantly improve the quality of life for individuals with Type 1 diabetes.
Related Concept Videos
01:23Tissue Renewal without Stem Cells
1.7K
After cellular or tissue damage, the resident stem cells present in the human body can locally repair and regenerate the damaged tissue or organ. However, even though some tissues do not have stem cells, they can repair and regenerate with the help of pre-existing cells. For example, beta cells of the pancreas and hepatocytes of the liver can divide to renew and regenerate the tissue. Here, both cell division and cell death are well regulated by homeostasis.
However, failure of such a system...
However, failure of such a system...
1.7K
01:22Diabetes Mellitus: Overview and Type I Subtype
2.4K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.4K
01:22iPS Cell Differentiation
2.6K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.6K
01:25Insulin: Biosynthesis, Chemistry, and Preparation
346
The endoplasmic reticulum (ER) of pancreatic β-cells synthesizes preproinsulin, which consists of a signal peptide, A and B chains, and a C-peptide. Preproinsulin is then cleaved and folded into proinsulin, which translocates to the Golgi apparatus for sorting and packaging into secretory granules. In these granules, enzymatic clipping generates insulin and C-peptide.
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment...
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment...
346
01:27Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
1.1K
The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
Insulin and C-peptide are...
1.1K
01:05Insulin Secretory Vesicles
4.8K
Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...
4.8K